| | | 63241 | | 16.04.2014 | | Labatec Pharma SA | | | | | | | | | | | | | 07.16.20. | | | | 07.16.20. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Octreotid Labatec 0,05 mg/mL | Solution pour injection | (Octreotidum 0.05 mg/ml) | H01CB02 | | | 02 | Octreotid Labatec 0,1 mg/mL | Solution pour injection | (Octreotidum 0.1 mg/ml) | H01CB02 | | | 04 | Octreotid Labatec 0,5 mg/mL | Solution pour injection | (Octreotidum 0.5 mg/ml) | H01CB02 | |
|
|
